✦ LIBER ✦

Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas

✍ Scribed by Kayser, Gian; Schulte-Uentrop, Luzie; Sienel, Wulf; Werner, Martin; Fisch, Paul; Passlick, Bernward; Hausen, Axel zur; Stremmel, Christian

Book ID: 119320751
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 978 KB
Volume: 76
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2012.01.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD80 expression in an HLA-A2-positive hu

CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer

✍ Dale L. Bixby; John R. Yannelli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix

Evaluation and Prognostic Significance o

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer

✍ Krebs, M. G.; Sloane, R.; Priest, L.; Lancashire, L.; Hou, J.-M.; Greystoke, A.; 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 266 KB

Psychosocial domain in quality of life a

Psychosocial domain in quality of life as an independent prognostic factor for survival and tumor response in patients with advanced non-small cell lung cancer (NSCLS)

✍ Matsumoto, T; Kobayashi, K; Eguchi, K; Shibuya, M; Morita, S; Ohashi, Y; Yamaji, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 110 KB

O-229 Prognostic value of cytokeratin-po

O-229 Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected non-small cell lung cancer: a multicenter prospective study

✍ Sugio, Kenji; Osaki, Toshihiro; Watanabe, Yoh; Kato, Harufumi; Mitsudomi, Tetsuy 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 317 KB

PD-159 Mutation in the tyrosine kinase d

PD-159 Mutation in the tyrosine kinase domain of epidermal growthfactor receptor (EGFR) is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer (NSCLC)

✍ Tsai, C.; Chiu, C.; Chou, T.; Li, L.; Chang, K.; Chen, Y.; Tsai, S.; Perng, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 139 KB

68O EFFICACY, SAFETY AND TOLERABILITY RE

68O EFFICACY, SAFETY AND TOLERABILITY RESULTS FROM A PHASE IV, OPEN-LABEL, SINGLE ARM STUDY OF 1ST-LINE GEFITINIB IN CAUCASIAN PATIENTS (PTS) WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION-POSITIVE NON-SMALL-CELL LUNG CANCER (NSCLC)

✍ Douillard, J.; Ostoros, G.; Cobo, M.; Ciuleanu, T.; McCormack, R.; Webster, A.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB